HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lawrence J Stern Selected Research

Hyperglycemia

1/2021Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lawrence J Stern Research Topics

Disease

8Infections
01/2021 - 04/2004
7Neoplasms (Cancer)
01/2022 - 01/2018
5Human Influenza (Influenza)
01/2017 - 12/2002
4Vaccinia
06/2013 - 10/2007
2Narcolepsy
01/2020 - 11/2019
2Inflammation (Inflammations)
01/2019 - 01/2019
2Communicable Diseases (Infectious Diseases)
10/2012 - 01/2009
2Malaria
01/2009 - 05/2006
2Smallpox (Variola)
10/2007 - 07/2007
1COVID-19
01/2022
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021
1Hyperglycemia
01/2021
1Epstein-Barr Virus Infections
11/2019
1Melanoma (Melanoma, Malignant)
08/2019
1Autoimmune Diseases (Autoimmune Disease)
01/2019
1Listeriosis (Listeria Infection)
01/2019
1Neoplasm Metastasis (Metastasis)
01/2018
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
02/2016
1Hypersensitivity (Allergy)
05/2012
1Muscular Dystrophies (Muscular Dystrophy)
05/2012
1Encephalitis (Encephalitis, Rasmussen)
05/2012
1Asthma (Bronchial Asthma)
07/2009
1Transfusion Reaction
08/2007
1Neonatal Alloimmune Thrombocytopenia
08/2007
1Ectromelia (Phocomelia)
07/2007
1Mpox (monkeypox)
07/2007
1Cowpox
07/2007
1Rheumatoid Arthritis
04/2006
1Decompression Sickness (Bends)
09/2004

Drug/Important Bio-Agent (IBA)

16Peptides (Polypeptides)IBA
01/2021 - 12/2002
9EpitopesIBA
01/2022 - 05/2006
7HLA-DR1 Antigen (HLA DR1 Antigen)IBA
10/2012 - 12/2002
5Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2004
4Histocompatibility Antigens Class IIIBA
01/2021 - 07/2007
4T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
10/2012 - 07/2007
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2019 - 09/2004
3Subunit VaccinesIBA
01/2009 - 05/2006
3VaccinesIBA
01/2009 - 07/2007
2AminopeptidasesIBA
01/2021 - 08/2019
2OrexinsIBA
01/2020 - 11/2019
2AntigensIBA
11/2019 - 01/2012
2LigandsIBA
01/2019 - 01/2019
2Viral AntigensIBA
01/2018 - 06/2010
2Pharmaceutical PreparationsIBA
01/2018 - 05/2012
2Viral ProteinsIBA
06/2013 - 07/2008
2Hemagglutinins (Hemagglutinin)IBA
01/2012 - 12/2002
1HLA-DQ5 antigenIBA
01/2022
1HLA-DPw4 antigenIBA
01/2022
1EnzymesIBA
01/2022
1mRNA VaccinesIBA
01/2022
1ApolipoproteinsIBA
01/2021
1Immunodominant EpitopesIBA
11/2019
1Histocompatibility Antigens Class IIBA
08/2019
1Immune Checkpoint InhibitorsIBA
08/2019
1Phosphotransferases (Kinase)IBA
01/2019
1tyrosine receptor (receptor, tyrosine)IBA
01/2019
1AutoantigensIBA
01/2019
1Glycoproteins (Glycoprotein)IBA
01/2019
1Actin Depolymerizing Factors (Cofilins)IBA
11/2017
1Serine Proteases (Serine Protease)IBA
11/2017
1Prealbumin (Transthyretin)IBA
02/2016
1Viral Core ProteinsIBA
10/2012
1HLA-DR4 Antigen (HLA DR4 Antigen)IBA
01/2012
1AllergensIBA
07/2009
1Biomarkers (Surrogate Marker)IBA
07/2009
1Human Immunodeficiency Virus ProteinsIBA
01/2007
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
05/2006
1GoldIBA
04/2006
1polypeptide CIBA
09/2004
1Interferon-gamma (Interferon, gamma)IBA
12/2002
1peptide AIBA
12/2002

Therapy/Procedure

2Immunotherapy
08/2019 - 07/2009
1Highly Active Antiretroviral Therapy (HAART)
01/2007
1Therapeutics
01/2007